Video Experimental Relacionado
Updated: Jan 8, 2026
09:57
System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
Published on: April 5, 2017
9.0K
El vínculo crítico entre el proceso de control de infecciones de TB y el impacto clínico: necesidad de datos de
Parth Aphale1, Shashank Dokania1, Himanshu Shekhar1
1Dr. D.Y. Patil Vidyapeeth (Deemed to be University), Pimpri, Pune, Maharashtra, India.
Journal of clinical tuberculosis and other mycobacterial diseases
|December 24, 2025
Resumen
Este estudio muestra una mejora en la implementación del Control de Infecciones de Tuberculosis (TBIC) en hospitales chinos. Sin embargo, cuestiona si tasas más altas realmente reflejan el impacto en la salud pública, especialmente para la tuberculosis multirresistente (MDR-TB).
Área de la Ciencia:
- Salud Pública
- Epidemiología de Enfermedades Infecciosas
- Gestión de la Atención Médica
Sus antecedentes:
- La tuberculosis sigue siendo un desafío importante para la salud mundial, lo que requiere estrategias efectivas de control de infecciones.
- Los entornos de alta incidencia requieren programas sólidos de Control de Infecciones de Tuberculosis (TBIC) para la contención de la enfermedad.
- Investigaciones anteriores resaltan la necesidad de evaluar las intervenciones de TBIC en diversos entornos de atención médica.
Objetivo del estudio:
- Evaluar la viabilidad y el impacto de las intervenciones programáticas en las tasas de implementación de TBIC.
- Evaluar el cumplimiento de los Controles Administrativos (AC), Controles Ambientales (EC) y Protección Respiratoria (RP).
- Examinar críticamente la correlación entre las tasas de implementación de TBIC y los resultados de salud pública, particularmente para la tuberculosis multirresistente (MDR-TB).
Principales métodos:
- Análisis retrospectivo de datos de implementación de TBIC de hospitales designados.
- Evaluación cuantitativa de las tasas de cumplimiento de las medidas de AC, EC y RP.
- Evaluación cualitativa del impacto en la salud pública de las mejoras observadas en TBIC.
Principales resultados:
- Se observaron mejoras significativas en las tasas generales de implementación de TBIC.
- Se documentó un aumento en el cumplimiento de los Controles Administrativos (AC), Controles Ambientales (EC) y Protección Respiratoria (RP).
- El estudio destaca la necesidad de una mayor investigación sobre el impacto directo en la salud pública.
Conclusiones:
- Las intervenciones programáticas pueden mejorar de manera factible las tasas de implementación de TBIC en entornos de alta incidencia.
- Si bien la mejora del cumplimiento es positiva, la medición del impacto en la salud pública requiere una mayor evaluación.
- La efectividad de TBIC, especialmente para MDR-TB, justifica una investigación continua y métricas de evaluación refinadas.
Videos de Conceptos Relacionados
01:26Pulmonary Tuberculosis IV
467
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
467
01:28Pulmonary Tuberculosis V
520
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
520
01:29Pulmonary Tuberculosis I
801
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
801
01:28Pulmonary Tuberculosis II
1.3K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.3K
01:29Therapeutic Drug Monitoring: Affecting Factors
170
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
170
01:31Pulmonary Tuberculosis III
884
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
884